These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Petrou S, Hockley C. Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981 [Abstract] [Full Text] [Related]
5. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort. Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054 [Abstract] [Full Text] [Related]
6. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G. J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564 [Abstract] [Full Text] [Related]
7. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F, Costs and Quality of Life in Rheumatoid Arthritis Study Group. Arthritis Rheum; 2006 Oct 15; 55(5):751-6. PubMed ID: 17013822 [Abstract] [Full Text] [Related]
8. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W. Clin Exp Rheumatol; 2011 Oct 15; 29(4):661-71. PubMed ID: 21813061 [Abstract] [Full Text] [Related]
10. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry. Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA. Arthritis Care Res (Hoboken); 2012 Jun 15; 64(6):826-32. PubMed ID: 22262513 [Abstract] [Full Text] [Related]
13. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders. Richardson SS, Berven S. Spine J; 2012 Jan 15; 12(1):55-62. PubMed ID: 22209244 [Abstract] [Full Text] [Related]
16. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM. Value Health; 2011 Jan 15; 14(5):732-9. PubMed ID: 21839412 [Abstract] [Full Text] [Related]
17. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D. Sørensen J, Linde L, Ostergaard M, Hetland ML. Value Health; 2012 Jan 15; 15(2):334-9. PubMed ID: 22433765 [Abstract] [Full Text] [Related]
18. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis. Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M. Pharmacoeconomics; 2010 Jan 15; 28(6):477-87. PubMed ID: 20465316 [Abstract] [Full Text] [Related]
20. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain. Søgaard R, Christensen FB, Videbaek TS, Bünger C, Christiansen T. Value Health; 2009 Jun 15; 12(4):606-12. PubMed ID: 19900258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]